article thumbnail

Announcing Our First Book: Origins

Codon

Our first book, Origins , is now available for purchase. The book is an ode to scientific progress, and the articles within tell stories about everything from the origins of synthetic biology to the discovery of an antimalarial drug in China and the invention of the micropipette. Purchase the Book You can read that here.

article thumbnail

Announcing Homeworld Ideas: A Writing Challenge

Codon

A good idea — presented clearly, backed by evidence, and packaged in a story — can help you raise money for a cause, rally people to an idea, or shift the directions of a field. Anyone can submit a piece in just about any format – poetry, essays, reportage, science fiction, book chapters, and so on.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

ChEMBL 34 is out!

The ChEMBL-og

A significant effort has been made to correctly map the drug form of the EMA data by manually inspecting different EMA sources of information, such as the Product Information (Annex I: Summary of Product Characteristics and Annex III: Labelling and Package Leaflet) and/or Assessment Report, where available. University of Dundee: T.

article thumbnail

Announcing Homeworld Ideas: A Writing Challenge

Codon

A good idea — presented clearly, backed by evidence, and packaged in a story — can help you raise money for a cause, rally people to an idea, or shift the directions of a field. Anyone can submit a piece in just about any format – poetry, essays, reportage, science fiction, book chapters, and so on.

article thumbnail

Keeping tabs on Covid-19: Cell and gene clinical trials advance despite Covid-19…

The Pharma Data

CluePoints provides clinical studies with risk management support package during Covid-19. Patrick Hughes, Co-Founder and Chief Commercial Officer of CluePoints, said: “The response to our complimentary risk assessment package has been fantastic. Download the e-book here. Source link.

article thumbnail

Is Recent Gene Therapy Setback for Duchenne Muscular Dystrophy (DMD) Déjà vu All Over Again?

PLOS: DNA Science

In the final chapter of my 2012 book The Forever Fix: Gene Therapy and the Boy Who Saved It , I predicted that the technology would soon expand well beyond the rare disease world. The package insert for the drug, Elevidys , warns of adverse effects of acute liver injury and inflammation around the heart and muscles.

article thumbnail

A Biotech Midsummer’s Madness

LifeSciVC

Instead, it was based on the large unmet need, the advantages of a unique ADC-based delivery platform, and a strong preclinical data package that supported this strategy. Regulatory Submissions, Meetings and Feedback How is the Briefing Book coming?